That's exactly when you can get the new Johnson & Johnson vaccine
The new unique shot vaccine will be available very soon.
The United States is currently in a race against the clock when states are trying toGet as many Americans vaccinated beforeThe variants begin to take over Nationwide. Now, a very exciting new development this weekend is about to do this mission a little easier: a third Johnson & Johnson Covid-19 vaccine has been approved for urgency use in the United States not only100% effective against hospitalizations and deathsBut it is also administered in one go, potentially doubling our progress to obtain the 70% coveted at 85% of the population vaccinated to reach the immunity of the flock. So, when will this new shooting be available? Earlier than you think, the experts say. Read to find out that the Johnson & Johnson vaccine can be on a site near you and for more information on the latest vaccine guides, see.Dr. Fauci has just said do not take this medicine with Covid vaccine.
The vaccine will start arriving on sites from Tuesday.
The first deliveries of the Johnson & Johnson vaccine could arrive from Tuesday after the Advisory Committee on Central Agriculture Centers and the United States Prevention (CDC) has adopted a unanimous vote on Sunday.Recommend the vaccine for widespread use For Americans over 18 years old.
During a Monday interview withToday,CEO of Johnson & Johnson Alex GorskySays: "Over the next 24 to 28 hours, Americans should start receiving shots in the arms. They literally flow with trucks as we speak." And for more vaccination news, you need to know, checkThe vaccine against Pfizer can be less effective if you have this common condition.
The first shipment represents only 4% of Johnson & Johnson's total commitment of 100 million doses.
The initial delivery must be 4 million doses. Johnson & Johnson plans to ship more than 20 million doses of vaccine at the end of March and 100 million doses by June, which is promised in the United States.Gorsky said during hisTodaymaintenance That Johnson & Johnson hopes to be "up to one billion by the end of 2021, adding:" We will work hard so that we follow all these commitments. " And for more regular Covid updates sent directly to your inbox,Sign up for our daily newsletter.
Johnson & Johnson vaccine is easier to deliver than Pfizer or Moderna.
In addition, requiring only one shot rather than two, the Johnson & Johnson vaccine differs from the shots of Pfizer and moderna in that it does not require freezing to maintain its effectiveness, which should facilitate transport through the country. While federal officials pointed out that the three vaccines should be uniformly available at the national level, it is not necessary that special storage and transport bottles will facilitate Johnson & Johnson bottles to provide areas and communities. more difficult to reach.
Officials are aware thatVaccination rates are currently lagging behind In minority communities in particular for a number of reasons. A senior head of the White House quoted by Reuters recently said: "Even if we know that the data is not complete, we see these first schemes suggesting that black and brown Americans are largely.get vaccinated at lower rates that representation in the general population. "
An attempt to solve this problem is the opening of400 Community vaccination centers In areas with large minority populations, as well as mobile vaccination units. Without the need to freeze or appointments for a reminder shot, hope is that this new Johnson & Johnson vaccine will help close this gap and to further protect Americans as soon as possible. And for more news about this new vaccine, checkThe Johnson & Johnson vaccine is 100% effective at this one thing.
Johnson's CEO & Johnson says there is a detail that people do not realize the newest vaccine.
There was a discussion thatJohnson & Johnson is the "weaker" vaccine, as its efficiency rate against symptomatic COVID in the United States is 72% against the protection of 95% of Moderna and Pfizer. But Gorsky explained how these numbers do not say the complete story. "What is really important to remember this vaccine is that when we led our clinical trials in October 2020 to the January 2021 benefit, it was during the time when the virus incidents were really At its peak, "he toldToday.
Gorsky said Johnson & Johnson's clinical trials were conducted worldwide, with 40% of patients in Latin America and 15% in South Africa, where theBrazilian and South African variantsrespectively increased more and more dominant. "When you look at the numbers around the vaccine, those who are the most important are that it works at 85% of the time against a serious illness and kept all patients from the hospital and die, even against these news Variants and really difficult., "Gorsky says. Meanwhile, Moderna and Pfizer vaccines were not tested against variants to more recently, so these pharmaceutical companies are working on Booster shots to protect against variants now. And for more information on the future of COVID vaccines, check The Pfizer CEO says how many times you will need a Covid vaccine .
